BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 20226028)

  • 1. Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma.
    Blattmann C; Oertel S; Schulz-Ertner D; Rieken S; Haufe S; Ewerbeck V; Unterberg A; Karapanagiotou-Schenkel I; Combs SE; Nikoghosyan A; Bischof M; Jäkel O; Huber P; Kulozik AE; Debus J
    BMC Cancer; 2010 Mar; 10():96. PubMed ID: 20226028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locally challenging osteo- and chondrogenic tumors of the axial skeleton: results of combined proton and photon radiation therapy using three-dimensional treatment planning.
    Hug EB; Fitzek MM; Liebsch NJ; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):467-76. PubMed ID: 7852108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy for local control of osteosarcoma.
    DeLaney TF; Park L; Goldberg SI; Hug EB; Liebsch NJ; Munzenrider JE; Suit HD
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):492-8. PubMed ID: 15667972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trial.
    Combs SE; Burkholder I; Edler L; Rieken S; Habermehl D; Jäkel O; Haberer T; Haselmann R; Unterberg A; Wick W; Debus J
    BMC Cancer; 2010 Oct; 10():533. PubMed ID: 20925951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Particle Therapy Using Protons or Carbon Ions for Unresectable or Incompletely Resected Bone and Soft Tissue Sarcomas of the Pelvis.
    Demizu Y; Jin D; Sulaiman NS; Nagano F; Terashima K; Tokumaru S; Akagi T; Fujii O; Daimon T; Sasaki R; Fuwa N; Okimoto T
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):367-374. PubMed ID: 28463156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study.
    Nikoghosyan AV; Rauch G; Münter MW; Jensen AD; Combs SE; Kieser M; Debus J
    BMC Cancer; 2010 Nov; 10():606. PubMed ID: 21050498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of combined ion-beam radiotherapy (CIBRT) with protons and carbon ions in a multimodal treatment strategy of inoperable osteosarcoma.
    Seidensaal K; Mattke M; Haufe S; Rathke H; Haberkorn U; Bougatf N; Kudak A; Blattmann C; Oertel S; Kirchner M; Buesch C; Kieser M; Herfarth K; Kulozik A; Debus J; Uhl M; Harrabi SB
    Radiother Oncol; 2021 Jun; 159():8-16. PubMed ID: 33549644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas.
    Kamada T; Tsujii H; Tsuji H; Yanagi T; Mizoe JE; Miyamoto T; Kato H; Yamada S; Morita S; Yoshikawa K; Kandatsu S; Tateishi A;
    J Clin Oncol; 2002 Nov; 20(22):4466-71. PubMed ID: 12431970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant irradiation of retroperitoneal soft tissue sarcoma with ions (Retro-Ion): study protocol for a randomized phase II pilot trial.
    Seidensaal K; Kieser M; Hommertgen A; Jaekel C; Harrabi SB; Herfarth K; Mechtesheimer G; Lehner B; Schneider M; Nienhueser H; Fröhling S; Egerer G; Debus J; Uhl M
    Trials; 2021 Feb; 22(1):134. PubMed ID: 33579340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant irradiation of extremity soft tissue sarcoma with ions (Extrem-ion): study protocol for a randomized phase II pilot trial.
    Brügemann D; Lehner B; Kieser M; Krisam J; Hommertgen A; Jaekel C; Harrabi SB; Herfarth K; Mechtesheimer G; Sedlaczek O; Egerer G; Geisbüsch A; Uhl M; Debus J; Seidensaal K
    BMC Cancer; 2022 May; 22(1):538. PubMed ID: 35550036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study.
    Nikoghosyan AV; Karapanagiotou-Schenkel I; Münter MW; Jensen AD; Combs SE; Debus J
    BMC Cancer; 2010 Nov; 10():607. PubMed ID: 21054824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heidelberg Ion Therapy Center (HIT): Initial clinical experience in the first 80 patients.
    Combs SE; Ellerbrock M; Haberer T; Habermehl D; Hoess A; Jäkel O; Jensen A; Klemm S; Münter M; Naumann J; Nikoghosyan A; Oertel S; Parodi K; Rieken S; Debus J
    Acta Oncol; 2010 Oct; 49(7):1132-40. PubMed ID: 20831505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of radiotherapy in oseosarcoma.
    Schwarz R; Bruland O; Cassoni A; Schomberg P; Bielack S
    Cancer Treat Res; 2009; 152():147-64. PubMed ID: 20213389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of carbon ion radiotherapy for unresectable osteosarcoma of the trunk.
    Matsunobu A; Imai R; Kamada T; Imaizumi T; Tsuji H; Tsujii H; Shioyama Y; Honda H; Tatezaki S;
    Cancer; 2012 Sep; 118(18):4555-63. PubMed ID: 22359113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study concepts.
    Rieken S; Habermehl D; Haberer T; Jaekel O; Debus J; Combs SE
    Radiat Oncol; 2012 Mar; 7():41. PubMed ID: 22436135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone.
    Shipley WU; Verhey LJ; Munzenrider JE; Suit HD; Urie MM; McManus PL; Young RH; Shipley JW; Zietman AL; Biggs PJ
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):3-12. PubMed ID: 7721636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities.
    Machak GN; Tkachev SI; Solovyev YN; Sinyukov PA; Ivanov SM; Kochergina NV; Ryjkov AD; Tepliakov VV; Bokhian BY; Glebovskaya VV
    Mayo Clin Proc; 2003 Feb; 78(2):147-55. PubMed ID: 12583525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: the MARCIE trial.
    Combs SE; Edler L; Burkholder I; Rieken S; Habermehl D; Jäkel O; Haberer T; Unterberg A; Wick W; Debus J; Haselmann R
    BMC Cancer; 2010 Nov; 10():615. PubMed ID: 21062428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy - including photon and proton therapy - for the treatment of radioresistant tumors: the ETOILE trial.
    Balosso J; Febvey-Combes O; Iung A; Lozano H; Alloh AS; Cornu C; Hervé M; Akkal Z; Lièvre M; Plattner V; Valvo F; Bono C; Fiore MR; Vitolo V; Vischioni B; Patin S; Allemand H; Gueyffier F; Margier J; Guerre P; Chabaud S; Orecchia R; Pommier P
    BMC Cancer; 2022 May; 22(1):575. PubMed ID: 35606739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.